世界のマイクロRNA市場2021-2028:製品別、サービス別、用途別(癌、神経疾患、感染症)、最終用途別、地域別

◆英語タイトル:microRNA Market Size, Share & Trends Analysis Report By Products, By Services, By Application (Cancer, Neurological Disease, Infectious Diseases), By End-use, By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21AP013
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年3月27日
◆ページ数:150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界のマイクロRNA市場規模が2028年までに36億ドルに達すると予測しています。2021年から2028年までに年平均19.8%成長する見通しです。本市場調査レポートでは、マイクロRNAの世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、産業動向、製品別(分離・精製ワークフロー・標本、器具、消耗品)分析、サービス別(単離・精製、miRNA・cDNA合成、プロファイリング・ローカリゼーション・定量化、機能分析、その他)分析、用途別(癌、感染症、免疫疾患、心血管疾患、神経疾患)分析、最終用途別(バイオテクノロジー・製薬会社、学術・政府研究機関、その他)分析、地域別分析、競争状況などの項目を掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・産業動向
・世界のマイクロRNA市場規模:製品別(分離・精製ワークフロー・標本、器具、消耗品)
・世界のマイクロRNA市場規模:サービス別(単離・精製、miRNA・cDNA合成、プロファイリング・ローカリゼーション・定量化、機能分析、その他)
・世界のマイクロRNA市場規模:用途別(癌、感染症、免疫疾患、心血管疾患、神経疾患)
・世界のマイクロRNA市場規模:最終用途別(バイオテクノロジー・製薬会社、学術・政府研究機関、その他)
・世界のマイクロRNA市場規模:地域別
・競争状況
【レポートの概要】

microRNA Market Growth & Trends

The global microRNA market size is expected to reach USD 3.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.8% from 2021 to 2028. Extensive research activities targeted towards exploring the potential functions of microRNA (miRNA) to design novel therapeutic solutions against different diseases is set to contribute to the adoption of miRNA instruments and consumables. These studies assist in understanding the mechanism of action of the signaling pathway, further integral to develop miRNA drug candidates.

For instance, in June 2020, Munich researchers have discovered that a specific microRNA helps in preserving the integrity of the endothelium and hence reducing the risk of atherosclerosis. Robust funding in biotechnology companies offering miRNA therapeutics is further propelling the influx of miRNA companies. For instance, in February 2021, InteRNA Technologies received a funding of USD 22.46 million in a Series B funding round, led by AurorA Science, an Italian biotech investment company.

The funding will support the clinical evaluation of INT-1B3, its microRNA lead candidate for treating patients with advanced solid tumors. In addition, the grants will help in advancing proprietary preclinical drug candidates for addressing a variety of cancer indications. Moreover, microRNAs (miRNAs) can influence the expression of certain genes, which makes it a potential solution for developing future medicine. Additionally, researchers are exploring the role of micro-RNA in the management of SARS-COV-2 infection. Studies have indicated that miRNAs play a vital role in regulating innate and adaptive immune systems.

Furthermore, studies have shown that the expression of these miRNAs has a role in the host’s response against the coronavirus and other respiratory viruses. Several in-silico experimentations have displayed that miRNA interactions with SARS-CoV-1 cause upregulation of some miRNA such as miR-574-5p, miR-17, and miR-214; helping in the inhibition of viral replication. Hence, studying the changes in miRNA expressions using sequencing instruments can contribute to understanding the pathogenesis of such chronic respiratory infections.

microRNA Market Report Highlights

• The consumables segment accounted for the largest revenue share in 2020 and is expected to continue the trend in the forecast period owing to the use of PCR consumables for facilitating efficient RNA purification and multiple enzymatic steps

• The instruments segment is expected to witness gradual growth through 2021 to 2028 owing to its high costing and established penetration of PCR instruments for sequencing miRNA

• The profiling, localization, and quantification instruments segment dominated the market as it is an integral step that is witnessing an influx of technological advancement

• For instance, the development of bead-based miRNA profiling involves specific oligonucleotide probes which are later detected using flow cytometry

• The isolation and purification is expected to witness the fastest CAGR through 2021 to 2028 owing to the gaining popularity of studying gene expression for the identification of diseases

• The infectious disease segment generated the highest revenue in 2020, attributed to a steep increase in the adoption of miRNA isolation and purification kits across COVID-19 research and diagnostic workflows

• miRNA isolates are emerging as fundamental components to assess SARS-COV-2 infection characteristics

• They are involved in mechanisms such as alteration in epigenetic regulation, genomic instabilities, biogenesis machinery defects, and aberrant transcriptional control

• The cardiovascular disease segment is expected to witness a lucrative growth rate of 16.1% owing to the rising application of miRNAs as biomarkers for cardiovascular disorders such as myocardial infarction, atherosclerosis, and coronary artery disease

• The academic and government research institutes is estimated to hold the largest market share owing to the high adoption of research tools for studying miRNA in research institutes

• North America emerged as the highest revenue-generating region, capturing more than 45.0% revenue share in 2020 owing to its strong patent base for microRNA

• Research institutes in the region are conducting extensive research activities to find a link between miRNA and metabolic disorders

• For instance, in October 2020, a group of researchers from Regents of the University of California discovered that a microRNA is associated with metabolic diseases such as type 2 diabetes obesity, and insulin resistance

• Asia Pacific is expected to witness lucrative growth through 2021 to 2028 due to developing research infrastructure and involvement of local players in manufacturing kits and reagents

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Scope & Segment Definition
1.3.1 Products Scope
1.3.2 Services Scope
1.3.3 Application
1.3.4 End-use
1.4 Market Model
1.4.1 Parent & ancillary market study
1.4.1.1 market, by SpecimeN
1.4.1.2 market, by Technology
1.4.2 Regional analysis
1.4.2.1 Region-wise market: Base estimates
1.4.3 Market study, by Company Market SHare
Chapter 2 Executive Summary
2.1 Market Snapshot, 2020
Chapter 3 Industry Outlook
3.1 Market Trends and Outlook
3.2 Market Segmentation & Scope
3.3 Penetration & Growth Prospect Mapping for Application, 2020
3.4 Market Dynamics
3.4.1 Market Drivers Analysis
3.4.1.1 Outbreak of COVID-19
3.4.1.2 Recent innovations in applications of miRNAs
3.4.1.2.1 Increased adoption for use as a biomarker
3.4.1.2.2 Therapeutic applications
3.4.1.3 High investments in miRNA R&D initiatives for development of new diagnostic tests & therapeutics
3.4.1.4 Success of miRNA in clinical trials
3.4.1.5 Technological advancements to support nucleic acid studies
3.4.1.6 Exponentially declining cost of sequencing
3.4.2 Market restraint Analysis
3.4.2.1 High cost associated with microRNA kits and other products
3.4.2.2 Challenges in handling RNA & in-house development of assays for microRNA detection
3.4.2.3 Poor reproducibility of research and specificity of products
3.4.2.4 Limited life science research infrastructure in emerging markets
3.5 Patent Review/ New Developments
3.6 Market Analysis & Tools
3.6.1 MicroRNA (miRNA) Market: SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6.2 Porter’s Five Forces Analysis
3.7 microRNA Market: Company Market Share Analysis
3.7.1 By Consumables (Kits & Reagents)
3.7.1.1 Company size 2020
3.7.1.2 Product portfolio
3.7.1.3 Geographic Presence
3.7.1.4 Strategic Initiatives
3.7.1.5 Conclusion
3.7.2 By Instruments
3.8 Impact of COVID-19 Pandemic
Chapter 4 MicroRNA (miRNA) Market Categorization: Products Business Analysis
4.1 MicroRNA (miRNA) Market: Products Movement Analysis
4.1.1 Global microRNA products market, 2017 – 2028 (USD Million)
4.1.2 By Isolation & Purification workflow, by Specimens
4.1.2.1 Whole Blood
4.1.2.1.1 Global microRNA consumables market for isolation and purification from whole blood specimens, 2017 – 2028 (USD Million)
4.1.2.2 Serum
4.1.2.2.1 Global microRNA consumables market for isolation and purification from serum specimens, 2017 – 2028 (USD Million)
4.1.2.3 Plasma
4.1.2.3.1 Global microRNA consumables market for isolation and purification from plasma specimens, 2017 – 2028 (USD Million)
4.1.2.4 FFPE
4.1.2.4.1 Global microRNA consumables market for isolation and purification from FFPE specimens, 2017 – 2028 (USD Million)
4.1.2.5 Fresh Frozen Tissue
4.1.2.5.1 Global microRNA consumables market for isolation and purification from fresh frozen tissue specimens, 2017 – 2028 (USD Million)
4.1.2.6 others
4.1.2.6.1 Global microRNA consumables market for isolation and purification from other specimens, 2017 – 2028 (USD Million)
4.1.3 Instruments
4.1.3.1 Global microRNA instruments market, 2017 – 2028 (USD Million)
4.1.3.2 By technology
4.1.3.2.1 PCR
4.1.3.2.1.1 Global Real Time PCR instruments market, 2017 – 2028 (USD Million)
4.1.3.2.2 NGS
4.1.3.2.2.1 Global NGS instruments market, 2017 – 2028 (USD Million)
4.1.3.2.3 Microarray
4.1.3.2.3.1 Global microarray instruments market, 2017 – 2028 (USD Million)
4.1.3.2.4 Others
4.1.3.2.4.1 Global other technologies market, 2017 – 2028 (USD Million)
4.1.3.3 By workflow
4.1.3.3.1 Isolation & purification
4.3.3.3.1.1 Global isolation and purification instruments market, 2017 – 2028 (USD Million)
4.3.3.3.2 miRNA cDNA Synthesis
4.3.3.3.2.1 Global miRNA cDNA synthesis instruments market, 2017 – 2028 (USD Million)
4.1.3.3.3 Profiling, Localization, & Quantification
4.1.3.3.3.1 Global Profiling, Localization, & Quantification instruments market, 2017 – 2028 (USD Million)
4.1.3.3.4 Functional Analysis
4.1.3.3.4.1 Global Functional analysis instruments market, 2017 – 2028 (USD Million)
4.1.3.3.5 Others
4.1.3.3.5.1.1 Global other workflows market, 2017 – 2028 (USD Million)
4.1.4 Consumables
4.1.4.1 Global microRNA consumables market, 2017 – 2028 (USD Million)
4.1.4.2 By Specimens
4.1.4.2.1 Whole blood
4.1.4.2.1.1 Global microRNA consumables market for whole blood specimens, 2017 – 2028 (USD Million)
4.1.4.2.2 Serum
4.1.4.2.2.1 Global microRNA consumables market for serum specimens, 2017 – 2028 (USD Million)
4.1.4.2.3 Plasma
4.1.4.2.3.1 Global microRNA consumables market for plasma specimens, 2017 – 2028 (USD Million)
4.1.4.2.4 FFPE
4.1.4.2.4.1 Global microRNA consumables market for FFPE specimens, 2017 – 2028 (USD Million)
4.1.4.2.5 Fresh Frozen Tissue
4.1.4.2.5.1 Global microRNA consumables market for Fresh Frozen Tissue specimens, 2017 – 2028 (USD Million)
4.1.4.2.6 Others
4.1.4.2.6.1 Global microRNA consumables market for other specimens, 2017 – 2028 (USD Million)
4.1.4.3 By workflow
4.1.4.3.1 Isolation and Purification
4.1.4.3.1.1 Global microRNA consumables market for isolation and purification, 2017 – 2028 (USD Million)
4.1.4.3.2 miRNA cDNA synthesis
4.1.4.3.3 Global microRNA consumables market for miRNA cDNA synthesis, 2017 – 2028 (USD Million)
4.1.4.3.4 Profiling, Localization, and Quantification
4.1.4.3.5 Global microRNA consumables market for Profiling, Localization, & Quantification, 2017 – 2028 (USD Million)
4.1.4.3.6 Functional Analysis
4.1.4.3.7 Global microRNA consumables market for functional analysis, 2017 – 2028 (USD Million)
4.1.4.3.8 Others
4.1.4.3.9 Global microRNA consumables market for other workflows, 2017 – 2028 (USD Million)
Chapter 5 MicroRNA (miRNA) Market Categorization: Services Business Analysis
5.1 MicroRNA (miRNA) Market: Services Movement Analysis
5.1.1 Global microrna services market, 2017 – 2028 (USD Million)
5.1.2 Service type
5.1.2.1 Isolation and Purification
5.1.2.1.1 Global Isolation and Purification services market, 2017 – 2028 (USD Million)
5.1.2.2 miRNA cDNA Synthesis
5.1.2.2.1 Global miRNA cDNA synthesis services market, 2017 – 2028 (USD Million)
5.1.2.3 Profiling, Localization, & Quantification
5.1.2.3.1 Global miRNA profiling, localization, and detection services market, 2017 – 2028 (USD Million)
5.1.2.4 Functional Analysis
5.1.2.4.1 Global miRNA functional studies services market, 2017 – 2028 (USD Million)
5.1.2.4.2 Next-Generation Sequencing (NGS)
5.2.2.4.2.1 Global NGS services market, 2017 – 2028 (USD Million)
5.1.2.4.3 microarray
5.1.2.4.3.1 Global microarray services market, 2017 – 2028 (USD Million)
5.1.2.4.4 Real Time – PCR (RT-PCR)
5.1.2.4.4.1 Global RT-PCR services market, 2017 – 2028 (USD Million)
5.1.2.4.5 Others
5.1.2.4.5.1 Global other functional analysis services market, 2017 – 2028 (USD Million)
5.1.2.5 Others
5.1.2.5.1 Global other services market, 2017 – 2028 (USD Million)
5.1.3 Sample collection/ specimen type
5.1.3.1 Whole blood
5.1.3.1.1 Global whole blood specimen market, 2017 – 2028 (USD Million)
5.1.3.2 Serum
5.1.3.2.1 Global serum specimen market, 2017 – 2028 (USD Million)
5.1.3.3 Plasma
5.1.3.3.1 Global plasma specimen market, 2017 – 2028 (USD Million)
5.1.3.4 FFPE
5.1.3.4.1 Global FFPE specimen market, 2017 – 2028 (USD Million)
5.1.3.5 Fresh Frozen Tissue
5.1.3.5.1 Global fresh frozen tissue specimen market, 2017 – 2028 (USD Million)
5.1.3.6 Others
5.1.3.6.1 Global other specimens market, 2017 – 2028 (USD Million)
Chapter 6 MicroRNA (miRNA) Market Categorization: Application Business Analysis
6.1 MicroRNA (miRNA) Market: Application Movement Analysis
6.2 Cancer
6.2.1 Global microRNA market for cancer, 2017 – 2028 (USD Million)
6.3 Infectious Diseases
6.3.1 Global microRNA market for infectious diseases, 2017 – 2028 (USD Million)
6.4 Immunological Disorders
6.4.1 Global microRNA market for Immunological Disorders, 2017 – 2028 (USD Million)
6.5 Cardiovascular Diseases
6.5.1 Global microRNA market for Cardiovascular Diseases, 2017 – 2028 (USD Million)
6.6 Neurological Diseases
6.6.1 Global microRNA market for neurological diseases, 2017 – 2028 (USD Million)
6.7 Other Applications
6.7.1 Global microRNA market for other applications, 2017 – 2028 (USD Million)
Chapter 7 MicroRNA (miRNA) Market Categorization: End-use Business Analysis
7.1 MicroRNA (miRNA) Market: End-use Movement Analysis
7.2 Biotechnology & Pharmaceutical Companies
7.2.1 Global microRNA market for Biotechnology & Pharmaceutical Companies, 2017 – 2028 (USD Million)
7.3 Academic & Government Research Institutes
7.3.1 Global microRNA market for Academic & Government Research Institutes, 2017 – 2028 (USD Million)
7.4 Others
7.4.1 Global microRNA market for others, 2017 – 2028 (USD Million)
Chapter 8 MicroRNA (miRNA) Market Categorization: Regional Business Analysis
8.1 MicroRNA (miRNA) Market Share by Regional, 2020 & 2028
8.2 North America
8.2.1 North America microRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. microRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.2.3 Canada
8.2.3.1 Canada MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.3 Europe
8.3.1 Europe MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.3.2 Germany
8.3.2.1 Germany MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.3.4 France
8.3.3.1 France MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.4 Asia Pacific
8.4.1 Asia pacific MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.4.2 Japan
8.4.2.1 Japan MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.4.3 China
8.4.3.1 China MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.4.4 INDIA
8.4.3.1 India MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.5 Latin America
8.5.1 Latin America MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.5.2 Brazil
8.5.2.1 brazil MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.6 Middle East and Africa (MEA)
8.6.1 MEA MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa MicroRNA market estimates and forecast, 2017 – 2028 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Merck KGaA
9.3.1.1 Company overview
9.3.1.2 Sigma-Aldrich Co. LLC
9.3.1.2.1 Company overview
9.3.1.3 Financial Performance
9.3.1.4 Product benchmarking
9.3.1.5 Strategic initiatives
9.3.2 QIAGEN
9.3.2.1 Company overview
9.3.2.2 Exiqon
9.3.2.3 Company overview
9.3.2.4 Financial Performance
9.3.2.5 Product benchmarking
9.3.2.6 Strategic initiatives
9.3.3 Horizon Discovery Group Co.
9.3.3.1 Company overview
9.3.3.2 Dharmacon, a Horizon Discovery Group Co
9.3.3.2.1 Company overview
9.3.3.3 Financial Performance
9.3.3.4 Product benchmarking
9.3.3.5 Strategic initiatives
9.3.4 Thermo Fisher Scientific, Inc.
9.3.4.1 Company overview
9.3.4.2 Financial Performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Synlogic
9.3.5.1 Company overview
9.3.5.2 Mirna Therapeutics Inc.
9.3.5.2.1 Company overview
9.3.5.3 Financial performance
9.3.5.4 Product benchmarking
9.3.5.5 Strategic initiatives
9.3.6 GeneCopoeia, Inc.
9.3.6.1 Company overview
9.3.6.2 Product benchmarking
9.3.7 New England Biolabs
9.3.7.1 Company overview
9.3.7.2 Financial Performance
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Quantabio
9.3.8.1 Company overview
9.3.8.2 Product benchmarking
9.3.8.3 Strategic initiatives
9.3.9 NanoString Technologies, Inc.
9.3.9.1 Company overview
9.3.9.2 Financial Performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Takara Bio, Inc.
9.3.10.1 Company overview
9.3.10.2 Financial Performance
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 LGC Limited
9.3.11.1 Company overview
9.3.11.2 Lucigen
9.3.11.2.1 Company overview
9.3.11.3 Financial Performance
9.3.11.4 Product benchmarking
9.3.11.5 Strategic initiatives
9.3.12 BioGenex
9.3.12.1 Company overview
9.3.12.2 Product benchmarking
9.3.12.3 Strategic initiatives
9.3.13 SeqMatic LLC
9.3.13.1 Company overview
9.3.13.2 Product benchmarking
9.3.14 Miltenyi Biotec
9.3.14.1 Company overview
9.3.14.2 Product benchmarking
9.3.15 Sistemic Scotland Limited
9.3.15.1 Company overview
9.3.15.2 Product benchmarking
9.3.15.3 Strategic initiatives
9.3.16 Biodynamics Laboratory, Inc.
9.3.16.1 Company overview
9.3.16.2 Product benchmarking
9.3.17 ORIGENE TECHNOLOGIES, INC.
9.3.17.1 Company overview
9.3.17.2 Financial Performance
9.3.17.3 Product benchmarking
9.3.17.4 Strategic initiatives
9.3.18 Norgen Biotek Corp.
9.3.18.1 Company overview
9.3.18.2 Product benchmarking
9.3.18.3 Strategic initiatives

List of Tables

TABLE 1 Amyotrophic Lateral Sclerosis and circulating miRNAs studied through miRNA profiling approach
TABLE 2 Parkinson’s disease and circulating miRNAs studied through miRNA profiling approach
TABLE 3 Developmental status of microRNA therapeutics
TABLE 4 Companies investing in RNA therapeutics
TABLE 5 Issued Patents Related to MicroRNA
TABLE 6 Therapeutics miRNA in development phase
TABLE 7 In vitro amplification technology
TABLE 8 Performance of different NGS platforms for miRNA differential expression
TABLE 9 Overview of miRNA array services
TABLE 10 Average salary by sector in USD
TABLE 11 Recent patent applications published by the USPTO (June 2017-April 2018)
TABLE 12 miRNA therapeutics in development
TABLE 13 Comparison of NGS and qPCR for miRNA studies
TABLE 14 Comparison of number of miRNAs identified using NGS & microarray platform in sample samples
TABLE 15 Mimics & inhibitors used in confirmation of miRNA gene targets
TABLE 16 List of biopharmaceutical companies developing RNA based therapeutics & vaccines
TABLE 17 Binary tree classification miRNAs for defined cancer types by Rosetta Genomics
TABLE 18 Comparison of prognosis predictor classifier performance over Support Vector Machine (SVM) with and without miRNA features
TABLE 19 List of infections medicated by miRNAs
TABLE 20 miRNAs identified with potential for prognostication post cardiac arrest
TABLE 21 miRNAs dysregulated in myocardia infraction using qPCR as detection method
TABLE 22 Alzheimer’s Disease and circulating miRNAs
TABLE 23 Multiple miRNAs common in regulating pathways in cancer and neurodegenerative diseases
TABLE 24 Same miRNAs controlling distinct pathways in cancer & neurodegenerative diseases
TABLE 25 miRNAs with potential application in dermatology
TABLE 26 North America microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 27 North America microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 28 North America microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 29 North America microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 30 North America microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 31 North America microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 32 North America microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 33 North America microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 34 North America microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 35 North America microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 36 North America microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 37 U.S. microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 38 U.S. microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 39 U.S. microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 40 U.S. microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 41 U.S. microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 42 U.S. microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 43 U.S. microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 44 U.S. microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 45 U.S. microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 46 U.S. microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 47 U.S. microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 48 Canada microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 49 Canada microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 50 Canada microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 51 Canada microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 52 Canada microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 53 Canada microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 54 Canada microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 55 Canada microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 56 Canada microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 57 Canada microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 58 Canada microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 59 Europe microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 60 Europe microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 61 Europe microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 62 Europe microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 63 Europe microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 64 Europe microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 65 Europe microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 66 Europe microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 67 Europe microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 68 Europe microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 69 Europe microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 70 Germany microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 71 Germany microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 72 Germany microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 73 Germany microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 74 Germany microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 75 Germany microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 76 Germany microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 77 Germany microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 78 Germany microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 79 Germany microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 80 Germany microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 81 U.K. microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 82 U.K. microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 83 U.K. microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 84 U.K. microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 85 U.K. microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 86 U.K. microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 87 U.K. microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 88 U.K. microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 89 U.K. microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 90 U.K. microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 91 U.K. microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 92 France microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 93 France microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 94 France microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 95 France microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 96 France microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 97 France microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 98 France microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 99 France microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 100 France microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 101 France microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 102 France microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 103 Asia Pacific microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 104 Asia Pacific microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 105 Asia Pacific microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 106 Asia Pacific microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 107 Asia Pacific microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 108 Asia Pacific microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 109 Asia Pacific microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 110 Asia Pacific microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 111 Asia Pacific microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 112 Asia Pacific microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 113 Asia Pacific microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 114 Japan microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 115 Japan microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 116 Japan microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 117 Japan microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 118 Japan microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 119 Japan microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 120 Japan microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 121 Japan microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 122 Japan microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 123 Japan microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 124 Japan microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 125 miRNAs targeted by anti-cancer Chinese medicinal herbs
TABLE 126 China microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 127 China microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 128 China microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 129 China microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 130 China microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 131 China microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 132 China microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 133 China microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 134 China microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 135 China microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 136 China microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 137 India microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 138 India microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 139 India microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 140 India microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 141 India microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 142 India microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 143 India microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 144 India microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 145 India microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 146 India microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 147 India microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 148 Latin America microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 149 Latin America microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 150 Latin America microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 151 Latin America microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 152 Latin America microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 153 Latin America microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 154 Latin America microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 155 Latin America microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 156 Latin America microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 157 Latin America microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 158 Latin America microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 159 Brazil microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 160 Brazil microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 161 Brazil microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 162 Brazil microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 163 Brazil microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 164 Brazil microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 165 Brazil microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 166 Brazil microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 167 Brazil microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 168 Brazil microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 169 Brazil microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 170 Middle East & Africa microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 171 Middle East & Africa microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 172 Middle East & Africa microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 173 Middle East & Africa microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 174 Middle East & Africa microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 175 Middle East & Africa microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 176 Middle East & Africa microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 177 Middle East & Africa microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 178 Middle East & Africa microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 179 Middle East & Africa microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 180 Middle East & Africa microRNA market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 181 South Africa microRNA market estimates & forecasts, by products, 2017 - 2028 (USD Million)
TABLE 182 South Africa microRNA market estimates & forecasts, by services, 2017 - 2028 (USD Million)
TABLE 183 South Africa microRNA services market estimates& forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 184 South Africa microRNA functional studies services market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 185 South Africa microRNA instruments market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 186 South Africa microRNA instruments market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 187 South Africa microRNA isolation & purification market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 188 South Africa microRNA consumables market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 189 South Africa microRNA isolation & purification consumables market estimates & forecasts, by specimen, 2017 - 2028 (USD Million)
TABLE 190 South Africa microRNA market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 191 South Africa microRNA market estimates & forecasts, by end use, 2017 - 2028 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Industry pyramid analysis
FIG. 4 Primary research workflow
FIG. 5 Market research approaches
FIG. 6 Value - chain - based sizing & forecasting
FIG. 7 QFD model assessment
FIG. 8 Industry pyramid analysis
FIG. 9 Factors considered for regional market share analysis
FIG. 10 QFD modeling workflow for company market share assessment
FIG. 11 Market snapshot (USD Million)
FIG. 12 Market trends & outlook
FIG. 13 Market segmentation & scope, by products & services
FIG. 14 Market segmentation & scope, by application & end - use scope
FIG. 15 Penetration & growth prospect mapping for applications, 2020
FIG. 16 Market driver relevance analysis (Current & future impact)
FIG. 17 Cost of raw megabase of DNA sequence, 2010 - 2020
FIG. 18 Cost of per human genome, 2010 - 2020
FIG. 19 Market restraint relevance analysis (Current & future impact)
FIG. 20 SWOT analysis, by factor (political & legal economic and technological)
FIG. 21 Porter’s Five Forces Analysis
FIG. 22 Global company market share analysis, by consumables (kits & reagents)
FIG. 23 Global company market share analysis, by Instruments
FIG. 24 End - users company market share analysis
FIG. 25 Consumables market share analysis for downstream assays
FIG. 26 Instruments Market Share Analysis for Downstream Assays
FIG. 27 MicroRNA market: Product & services outlook and key takeaways
FIG. 28 MicroRNA market: Product & services movement analysis
FIG. 29 Global microRNA services market, 2017 - 2028 (USD Million)
FIG. 30 Global isolation and purification services market, 2017 - 2028 (USD Million)
FIG. 31 Global miRNA cDNA synthesis services market, 2017 - 2028 (USD Million)
FIG. 32 Global miRNA profiling, localization, and Quantification services market, 2017 - 2028 (USD Million)
FIG. 33 Global miRNA functional analysis services market, 2017 - 2028 (USD Million)
FIG. 34 Global NGS services market, 2017 - 2028 (USD Million)
FIG. 35 Global microarray services market, 2017 - 2028 (USD Million)
FIG. 36 Global RT - PCR services market, 2017 - 2028 (USD Million)
FIG. 37 Global other functional analysis services market, 2017 - 2028 (USD Million)
FIG. 38 Global other services market, 2017 - 2028 (USD Million)
FIG. 39 Global whole blood specimen market, 2017 - 2028 (USD Million)
FIG. 40 Global serum specimen market, 2017 - 2028 (USD Million)
FIG. 41 Global plasma specimen market, 2017 - 2028 (USD Million)
FIG. 42 Global FFPE specimen market, 2017 - 2028 (USD Million)
FIG. 43 Global fresh frozen tissue specimen market, 2017 - 2028 (USD Million)
FIG. 44 Global other specimens market, 2017 - 2028 (USD Million)
FIG. 45 Global microRNA products market, 2017 - 2028 (USD Million)
FIG. 46 Global microRNA consumables market for isolation and purification from whole blood specimens, 2017 - 2028 (USD Million)
FIG. 47 Global microRNA consumables market for isolation and purification from serum specimens, 2017 - 2028 (USD Million)
FIG. 48 Global microRNA consumables market for isolation and purification from plasma specimens, 2017 - 2028 (USD Million)
FIG. 49 Global microRNA consumables market for isolation and purification from FFPE specimens, 2017 - 2028 (USD Million)
FIG. 50 Global microRNA consumables market for isolation and purification from fresh frozen tissue specimens, 2017 - 2028 (USD Million)
FIG. 51 Global microRNA consumables market for isolation and purification from other specimens, 2017 - 2028 (USD Million)
FIG. 52 Global microRNA instruments market, 2017 - 2028 (USD Million)
FIG. 53 Global real time PCR instruments market, 2017 - 2028 (USD Million)
FIG. 54 Global NGS instruments market, 2017 - 2028 (USD Million)
FIG. 55 Global microarray instruments market, 2017 - 2028 (USD Million)
FIG. 56 Global other technologies market, 2017 - 2028 (USD Million)
FIG. 57 Global isolation and purification instruments market, 2017 - 2028 (USD Million)
FIG. 58 Global miRNA cDNA synthesis instruments market, 2017 - 2028 (USD Million)
FIG. 59 Global profiling, localization, & quantification instruments market, 2017 - 2028 (USD Million)
FIG. 60 Global functional analysis instruments market, 2017 - 2028 (USD Million)
FIG. 61 Global other workflows market, 2017 - 2028 (USD Million)
FIG. 62 Global microRNA consumables market, 2017 - 2028 (USD Million)
FIG. 63 Global microRNA consumables market for whole blood specimens, 2017 - 2028 (USD Million)
FIG. 64 Global microRNA consumables market for serum specimens, 2017 - 2028 (USD Million)
FIG. 65 Global microRNA consumables market for plasma specimens, 2017 - 2028 (USD Million)
FIG. 66 Global microRNA consumables market for FFPE specimens, 2017 - 2028 (USD Million)
FIG. 67 Global microRNA consumables market for fresh frozen tissue specimens, 2017 - 2028 (USD Million)
FIG. 68 Global microRNA consumables market for other specimens, 2017 - 2028 (USD Million)
FIG. 69 Global microRNA consumables market for isolation and purification, 2017 - 2028 (USD Million)
FIG. 70 Global microRNA consumables market for miRNA cDNA synthesis, 2017 - 2028 (USD Million)
FIG. 71 Global microRNA consumables market for profiling, localization, & quantification, 2017 - 2028 (USD Million)
FIG. 72 Global microRNA consumables market for functional analysis, 2017 - 2028 (USD Million)
FIG. 73 Global microRNA consumables market for other workflows, 2017 - 2028 (USD Million)
FIG. 74 MicroRNA market: Application outlook and key takeaways
FIG. 75 MicroRNA market: Application movement analysis
FIG. 76 Global microRNA market for cancer, 2017 - 2028 (USD Million)
FIG. 77 Global microRNA market for infectious diseases, 2017 - 2028 (USD Million)
FIG. 78 Global microRNA market for immunological disorders, 2017 - 2028 (USD Million)
FIG. 79 Global microRNA market for cardiovascular diseases, 2017 - 2028 (USD Million)
FIG. 80 Global microRNA market for neurological diseases, 2017 - 2028 (USD Million)
FIG. 81 Global microRNA market for other applications, 2017 - 2028 (USD Million)
FIG. 82 MicroRNA market: End - use outlook and key takeaways
FIG. 83 MicroRNA market: End - use movement analysis
FIG. 84 Global microRNA market for biotechnology & pharmaceutical companies, 2017 - 2028 (USD Million)
FIG. 85 Global microRNA market for academic & government research institutes, 2017 - 2028 (USD Million)
FIG. 86 Global microRNA market for others, 2017 - 2028 (USD Million)
FIG. 87 MicroRNA market: Regional outlook and key takeaways
FIG. 88 MicroRNA market: Regional movement analysis, 2020 and 2028
FIG. 89 North America microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 90 U.S. microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 91 Canada microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 92 Europe microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 93 Germany microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 94 U.K. microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 95 France microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 96 Asia Pacific microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 97 Japan microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 98 China microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 99 India microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 100 Latin America microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 101 Brazil microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 102 MEA microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 103 South Africa microRNA market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 104 Strategy framework
FIG. 105 Market participation categorization

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のマイクロRNA市場2021-2028:製品別、サービス別、用途別(癌、神経疾患、感染症)、最終用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆